Featured · Medicare & Medicaid
The GLP-1 Bridge Program: Price Fixing vs. Free Market Healthcare
In the latest episode of the Health Policy Podcast, host Bryan Hyde speaks with Jay Goldberg, North American Affairs Manager at the Consumer Choice Center, about the GLP-1 Bridge Program. This program, initiated by the Trump administration, aims to provide lower-cost weight loss drugs to Medicare and Medicaid recipients but raises concerns about price fixing and its potential impact on medical innovation. Goldberg argues for the benefits of free market competition in healthcare, emphasizing that government intervention can lead to unintended consequences, including reduced access to new medications.
2026-09-24 · with Jay Goldberg
